InvestorsHub Logo
Followers 3
Posts 354
Boards Moderated 0
Alias Born 11/03/2017

Re: FDApproved post# 12808

Wednesday, 06/13/2018 11:26:43 AM

Wednesday, June 13, 2018 11:26:43 AM

Post# of 44784
Thank you, Allo. It seems the news are getting better and better (regardless of the share price). If I understand the content of the link below correctly, positive interim results for the CLI trial may set the scene for early marketing approval in Europe. Exciting times.

"PLX-PAD cells have been selected by the European Medicines Agency (EMA) to be developed for CLI via the Adaptive Pathways pilot project. Under this regulatory pathway, the multinational Phase III trial may potentially lead to early marketing approval of PLX-PAD for CLI in Europe, based on interim efficacy data from the first 125 patients that have completed a follow-up of 12 months."

https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=754157&;

Can I hear a "MOLTO bellissimo" in the distance? I certainly hope so.

HappyBee